Biomarin Pharmaceutical Inc (BMRN)
66.60
+0.71
(+1.08%)
USD |
NASDAQ |
Nov 01, 16:00
66.60
0.00 (0.00%)
After-Hours: 20:00
Biomarin Pharmaceutical Price to Book Value: 2.345 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.345 |
| October 31, 2024 | 2.320 |
| October 30, 2024 | 2.348 |
| October 29, 2024 | 2.461 |
| October 28, 2024 | 2.469 |
| October 25, 2024 | 2.454 |
| October 24, 2024 | 2.478 |
| October 23, 2024 | 2.463 |
| October 22, 2024 | 2.483 |
| October 21, 2024 | 2.474 |
| October 18, 2024 | 2.468 |
| October 17, 2024 | 2.445 |
| October 16, 2024 | 2.470 |
| October 15, 2024 | 2.480 |
| October 14, 2024 | 2.474 |
| October 11, 2024 | 2.476 |
| October 10, 2024 | 2.459 |
| October 09, 2024 | 2.457 |
| October 08, 2024 | 2.418 |
| October 07, 2024 | 2.427 |
| October 04, 2024 | 2.447 |
| October 03, 2024 | 2.399 |
| October 02, 2024 | 2.452 |
| October 01, 2024 | 2.468 |
| September 30, 2024 | 2.474 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.542 |
| September 26, 2024 | 2.530 |
| September 25, 2024 | 2.486 |
| September 24, 2024 | 2.502 |
| September 23, 2024 | 2.490 |
| September 20, 2024 | 2.546 |
| September 19, 2024 | 2.572 |
| September 18, 2024 | 2.562 |
| September 17, 2024 | 2.541 |
| September 16, 2024 | 2.516 |
| September 13, 2024 | 3.058 |
| September 12, 2024 | 3.039 |
| September 11, 2024 | 3.053 |
| September 10, 2024 | 3.056 |
| September 09, 2024 | 3.037 |
| September 06, 2024 | 3.028 |
| September 05, 2024 | 3.066 |
| September 04, 2024 | 3.236 |
| September 03, 2024 | 3.299 |
| August 30, 2024 | 3.285 |
| August 29, 2024 | 3.291 |
| August 28, 2024 | 3.253 |
| August 27, 2024 | 3.258 |
| August 26, 2024 | 3.241 |
| August 23, 2024 | 3.242 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.320
Minimum
Oct 31 2024
7.333
Maximum
Jul 20 2020
3.824
Average
3.567
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 5.926 |
| Bristol-Myers Squibb Co | 6.427 |
| Alnylam Pharmaceuticals Inc | 1091.96 |
| Bioventus Inc | 5.855 |
| Moderna Inc | 1.793 |
Price to Book Value Related Metrics
| PE Ratio | 39.88 |
| PS Ratio | 4.750 |
| PEG Ratio | 0.3401 |
| Price to Free Cash Flow | 43.46 |
| Price | 66.60 |
| Earnings Yield | 2.51% |
| Market Cap | 12.69B |
| PEGY Ratio | 0.3401 |
| Operating PE Ratio | 41.86 |
| Normalized PE Ratio | 40.91 |